SOD1 and DJ-1 converge at Nrf2 pathway: A clue for antioxidant therapeutic potential in neurodegeneration

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Milani, Pamela ^a,b   Ambrosi, Giulia ^a,b   Gammoh, Omar ^a,b,c   Blandini, Fabio ^a   Cereda, Cristina ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c AMERICAN UNIVERSITY OF MADABA   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT PROTEINS; MASTER REGULATORS; PARKINSON'S DISEASE; REACTIVE OXYGEN SPECIES; THERAPEUTIC EFFICACY; THERAPEUTIC POTENTIALS; TRANSCRIPTIONAL FACTORS;

ANTIOXIDANTS; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; PROTEINS;

NEURODEGENERATIVE DISEASES;

AZATHIOPRINE; BROMOCRIPTINE; CARNOSIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; CURCUMIN; DJ 1 PROTEIN; EPIGALLOCATECHIN GALLATE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GENISTEIN; GLUTATHIONE TRANSFERASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MANGANESE SUPEROXIDE DISMUTASE; NAPHTHAZARIN; PEROXIREDOXIN; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; TRITERPENOID; ANTIOXIDANT; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; SIGNAL PEPTIDE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; AUTOPHAGY; CELL INCLUSION; DOPAMINERGIC NERVE CELL; EXCITOTOXICITY; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; MOTONEURON; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION STATE; PARKINSON DISEASE; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; RNA METABOLISM; SUBSTANTIA NIGRA PARS COMPACTA; UBIQUITINATION; ANIMAL; DEGENERATIVE DISEASE; DRUG EFFECT; METABOLISM; OXIDATIVE STRESS; REVIEW; DRUG EFFECTS; NEURODEGENERATIVE DISEASES;

ANIMALS; ANTIOXIDANTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR 2; ONCOGENE PROTEINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84883179994     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/836760     Document Type: Article

References (128)

1. Halliwell B., Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry 2006 97 6 1634 1658 2-s2.0-33745013111 10.1111/j.1471-4159.2006.03907.x
2. Melo A., Monteiro L., Lima R. M. F., de Oliveira D. M., de Cerqueira M. D., El-Bachá R. S., Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxidative Medicine and Cellular Longevity 2011 2-s2.0-84855584833 10.1155/2011/467180 467180
3. Gandhi S., Abramov A. Y., Mechanism of oxidative stress in neurodegeneration. Oxidative Medicine and Cellular Longevity 2012 2012 11 428010 10.1155/2012/428010
4. Jimenez-Del-Rio M., Velez-Pardo C., The bad, the good, and the ugly about oxidative stress. Oxidative Medicine and Cellular Longevity 2012 2012 13 163913 10.1155/2012/163913
5. Hernandes M. S., Britto L. R., NADPH oxidase and neurodegeneration. Current Neuropharmacology 2012 10 4 321 327
6. Orsini F., Moroni M., Contursi C., Yano M., Pelicci P., Giorgio M., Migliaccio E., Regulatory effects of the mitochondrial energetic status on mitochondrial p66Shc. Biological Chemistry 2006 387 10-11 1405 1410 2-s2.0-33750618076 10.1515/BC.2006.176
7. Pryor W. A., Squadrito G. L., The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. American Journal of Physiology 1995 268 5 L699 L722 2-s2.0-0029037495
8. Martínez M. C., Andriantsitohaina R., Reactive nitrogen species: molecular mechanisms and potential significance in health and disease. Antioxidants and Redox Signaling 2009 11 3 669 702 2-s2.0-58849158293 10.1089/ars.2007.1993
9. Trachootham D., Lu W., Ogasawara M. A., Valle N. R.-D., Huang P., Redox regulation of cell survival. Antioxidants and Redox Signaling 2008 10 8 1343 1374 2-s2.0-51749088156 10.1089/ars.2007.1957
10. Halliwell B., Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs and Aging 2001 18 9 685 716 2-s2.0-0034796353
11. Son Y., Cheong Y. K., Kim N. H., Chung H. T., Kang D. G., Pae H. O., Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? Journal of Signal Transduction 2011 2011 6 792639 10.1155/2011/792639
12. Yan Y., Wei C.-L., Zhang W.-R., Cheng H.-P., Liu J., Cross-talk between calcium and reactive oxygen species signaling. Acta Pharmacologica Sinica 2006 27 7 821 826 2-s2.0-33748561167 10.1111/j.1745-7254.2006.00390.x
13. Feissner R. F., Skalska J., Gaum W. E., Sheu S.-S., Crosstalk signaling between mitochondrial Ca2+ and ROS. Frontiers in Bioscience 2009 14 4 1197 1218 2-s2.0-63849184477 10.2741/3303
14. Ma Q., Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacology and Therapeutics 2010 125 3 376 393 2-s2.0-77049114949 10.1016/j.pharmthera.2009.11.004
15. Allen R. G., Tresini M., Oxidative stress and gene regulation. Free Radical Biology and Medicine 2000 28 3 463 499 2-s2.0-0033963704 10.1016/S0891-5849(99)00242-7
16. Vieira H. L. A., Alves P. M., Vercelli A., Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species. Progress in Neurobiology 2011 93 3 444 455 2-s2.0-79951792636 10.1016/j.pneurobio.2011.01. 007
17. Kennedy K. A. M., Sandiford S. D. E., Skerjanc I. S., Li S. S.-C., Reactive oxygen species and the neuronal fate. Cellular and Molecular Life Sciences 2012 69 2 215 221 2-s2.0-84856215752 10.1007/s00018-011-0807-2
18. de Lau L. M., Breteler M. M., Epidemiology of Parkinson's disease. The Lancet Neurology 2006 5 6 525 535 2-s2.0-33745919520 10.1016/S1474-4422(06) 70471-9
19. Xiromerisiou G., Dardiotis E., Tsimourtou V., Kountra P. M., Paterakis K. N., Kapsalaki E. Z., Fountas K. N., Hadjigeorgiou G. M., Genetic basis of Parkinson disease. Neurosurgical Focus 2010 28 1 E7.1 E7.7 2-s2.0-76549113425 10.3171/2009.10.FOCUS09220
20. Kumar H., Lim H. W., More S. V., Kim B. W., Koppula S., Kim I. S., Choi D. K., The role of free radicals in the aging brain and Parkinson's disease: convergence and parallelism. International Journal of Molecular Sciences 2012 13 8 10478 10504
21. Greenamyre J. T., Hastings T. G., Parkinsons-divergent causes convergent mechanisms. Science 2004 304 5674 1120 1122 2-s2.0-2442636348 10.1126/science.1098966
22. Chaturvedi R. K., Beal M. F., Mitochondrial diseases of the brain. Free Radical Biology and Medicine 2013 63 1 29 10.1016/j.freeradbiomed.2013.03.018
23. Schapira A. H. V., Hartley A., Cleeter M. W. J., Cooper J. M., Free radicals and mitochondrial dysfunction in Parkinson's disease. Biochemical Society Transactions 1993 21 2 367 370 2-s2.0-0027253159
24. Navarro A., Boveris A., Bández M. J., Sánchez-Pino M. J., Gómez C., Muntané G., Ferrer I., Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radical Biology and Medicine 2009 46 12 1574 1580 2-s2.0-67349122601 10.1016/j.freeradbiomed.2009.03.007
25. Buhmann C., Arlt S., Kontush A., Möller-Bertram T., Sperber S., Oechsner M., Stuerenburg H.-J., Beisiegel U., Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication. Neurobiology of Disease 2004 15 1 160 170 2-s2.0-1642538395 10.1016/j.nbd.2003.10.003
26. Isobe C., Abe T., Terayama Y., Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neuroscience Letters 2010 469 1 159 163 2-s2.0-72649092390 10.1016/j.neulet.2009.11.065
27. Nikam S., Nikam P., Ahaley S. K., Sontakke A. V., Oxidative stress in Parkinson's disease. Indian Journal of Clinical Biochemistry 2009 24 1 98 101 2-s2.0-65649106909 10.1007/s12291-009-0017-y
28. Jazwa A., Rojo A. I., Innamorato N. G., Hesse M., Fernández-Ruiz J., Cuadrado A., Pharmacological targeting of the transcription factor NRf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxidants and Redox Signaling 2011 14 12 2347 2360 2-s2.0-79957515007 10.1089/ars.2010.3731
29. Williamson T. P., Johnson D. A., Johnson J. A., Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity. NeuroToxicology 2012 33 3 272 279 2-s2.0-84858744802 10.1016/j.neuro.2012.01.015
30. Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P. L., Excitotoxicity: bridge to various triggers in neurodegenerative disorders. European Journal of Pharmacology 2013 698 1-3 6 18
31. Peterson L. J., Flood P. M., Oxidative stress and microglial cells in Parkinson's disease. Mediators of Inflammation 2012 2012 12 401264 10.1155/2012/401264
32. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993 362 6415 59 62 2-s2.0-0027401203 10.1038/362059a0
33. Pasinelli P., Brown R. H., Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nature Reviews Neuroscience 2006 7 9 710 723 2-s2.0-33747605320 10.1038/nrn1971
34. Cozzolino M., Pesaresi M. G., Gerbino V., Grosskreutz J., Carri M. T., Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxidants & Redox Signaling 2012 17 9 1277 1330
35. Gagliardi S., Milani P., Sardone V., Pansarasa O., Cereda C., From transcriptome to noncoding RNAs: implications in ALS mechanism. Neurology Research International 2012 2012 7 278725 10.1155/2012/278725
36. Rossi L., Valle C., Carri M. T., Altered gene expression, mitochondrial damage and oxidative stress: converging routes in motor neuron degeneration. International Journal of Cell Biology 2012 2012 9 908724 10.1155/2012/908724
37. Strong M. J., The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). Journal of the Neurological Sciences 2010 288 1-2 1 12 2-s2.0-71049166754 10.1016/j.jns.2009.09.029
38. Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., Kowall N. W., Brown R. H. Jr., Beal M. F., Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. Journal of Neurochemistry 1997 69 5 2064 2074 2-s2.0-0030813067
39. Barber S. C., Mead R. J., Shaw P. J., Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochimica et Biophysica Acta 2006 1762 11-12 1051 1067 2-s2.0-33751003518 10.1016/j.bbadis.2006.03.008
40. Barber S. C., Shaw P. J., Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radical Biology and Medicine 2010 48 5 629 641 2-s2.0-75149155060 10.1016/j.freeradbiomed.2009.11.018
41. Abe K., Pan L.-H., Watanabe M., Kato T., Itoyama Y., Induction of nitrotyrsone-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neuroscience Letters 1995 199 2 152 154 2-s2.0-0028971936 10.1016/0304-3940(95)12039-7
42. Beal M. F., Ferrante R. J., Browne S. E., Matthews R. T., Kowall N. W., Brown R. H. Jr., Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Annals of Neurology 1997 42 4 644 654 2-s2.0-0030851761 10.1002/ana.410420416
43. Shaw P. J., Ince P. G., Falkous G., Mantle D., Oxidative damage to protein in sporadic motor neuron disease spinal cord. Annals of Neurology 1995 38 4 691 695 2-s2.0-0029082389 10.1002/ana.410380424
44. Cutler R. G., Pedersen W. A., Camandola S., Rothstein J. D., Mattson M. P., Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Annals of Neurology 2002 52 4 448 457 2-s2.0-0036789845 10.1002/ana.10312
45. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S., Smith R. G., Kasarskis E., Mattson M. P., Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Annals of Neurology 1998 44 5 819 824 2-s2.0-0031768026
46. Smith R. G., Henry Y. K., Mattson M. P., Appel S. H., Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Annals of Neurology 1998 44 4 696 699 2-s2.0-0031722955 10.1002/ana.410440419
47. Simpson E. P., Henry Y. K., Henkel J. S., Smith R. G., Appel S. H., Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 2004 62 10 1758 1765 2-s2.0-2442701519
48. Carrì M. T., Cozzolino M., SOD1 and mitochondria in ALS: a dangerous liaison. Journal of Bioenergetics and Biomembranes 2011 43 6 593 599 2-s2.0-84857063826 10.1007/s10863-011-9394-z
49. Martin L. J., Mitochondrial pathobiology in ALS. Journal of Bioenergetics and Biomembranes 2011 43 6 569 579
50. Manfredi G., Xu Z., Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 2005 5 2 77 87 2-s2.0-16844366080 10.1016/j.mito.2005.01.002
51. Curti D., Malaspina A., Facchetti G., Camana C., Mazzini L., Tosca P., Zerbi F., Ceroni M., Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 1996 47 4 1060 1064 2-s2.0-0029809528
52. Kong J., Xu Z., Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. Journal of Neuroscience 1998 18 9 3241 3250 2-s2.0-0032079517
53. Wiedemann F. R., Manfredi G., Mawrin C., Beal M. F., Schon E. A., Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. Journal of Neurochemistry 2002 80 4 616 625 2-s2.0-0036321382 10.1046/j.0022-3042.2001.00731.x
54. Usarek E., Gajewska B., Kaźmierczak B., Kuźma M., Dziewulska D., Barańczyk-Kuźma A., A study of glutathione S-transferase pi expression in central nervous system of subjects with amyotrophic lateral sclerosis using RNA extraction from formalin-fixed, paraffin-embedded material. Neurochemical Research 2005 30 8 1003 1007 2-s2.0-27644477778 10.1007/s11064-005-6771-1
55. Kuzma M., Jamrozik Z., Baranczyk-Kuzma A., Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis. Clinica Chimica Acta 2006 364 1-2 217 221
56. Kato S., Kato M., Abe Y., Matsumura T., Nishino T., Aoki M., Itoyama Y., Asayama K., Awaya A., Hirano A., Ohama E., Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathologica 2005 110 2 101 112 2-s2.0-33644629020
57. Kirby J., Halligan E., Baptista M. J., Allen S., Heath P. R., Holden H., Barber S. C., Loynes C. A., Wood-Allum C. A., Lunec J., Shaw P. J., Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain 2005 128 7 1686 1706 2-s2.0-21944454604 10.1093/brain/awh503
58. Sarlette A., Krampfl K., Grothe C., Neuhoff N. V., Dengler R., Petri S., Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology 2008 67 11 1055 1062 2-s2.0-58149232639 10.1097/NEN.0b013e31818b4906
59. Mimoto T., Miyazaki K., Morimoto N., Kurata T., Satoh K., Ikeda Y., Abe K., Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Research 2012 1446 109 118 2-s2.0-84858451400 10.1016/j.brainres.2011.12.064
60. Petri S., Korner S., Kiaei M., Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurology Research International 2012 2012 7 878030 10.1155/2012/878030
61. Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S. M. M., Ariga H., DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochemical and Biophysical Research Communications 1997 231 2 509 513 2-s2.0-0031566231 10.1006/bbrc.1997.6132
62. Wagenfeld A., Gromoll J., Cooper T. G., Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization. Biochemical and Biophysical Research Communications 1998 251 2 545 549 2-s2.0-0032552851 10.1006/bbrc.1998.9512
63. Bonifati V., Rizzu P., van Baren M. J., Schaap O., Breedveld G. J., Krieger E., Dekker M. C. J., Squitieri F., Ibanez P., Joosse M., Van Dongen J. W., Vanacore N., Van Swieten J. C., Brice A., Meco G., Van Duijn C. M., Oostra B. A., Heutink P., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003 299 5604 256 259 2-s2.0-0037428241 10.1126/science.1077209
64. Honbou K., Suzuki N. N., Horiuchi M., Niki T., Taira T., Ariga H., Inagaki F., The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. Journal of Biological Chemistry 2003 278 33 31380 31384 2-s2.0-0042232029 10.1074/jbc.M305878200
65. Huai Q., Sun Y., Wang H., Chin L.-S., Li L., Robinson H., Ke H., Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. FEBS Letters 2003 549 1-3 171 175 2-s2.0-0042063899 10.1016/S0014-5793(03)00764-6
66. Tao X., Tong L., Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. Journal of Biological Chemistry 2003 278 33 31372 31379 2-s2.0-0042232039 10.1074/jbc.M304221200
67. Wilson M. A., Collins J. L., Hod Y., Ringe D., Petsko G. A., The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9256 9261 2-s2.0-0042130551 10.1073/pnas.1133288100
68. Lakshminarasimhan M., Maldonado M. T., Zhou W., Fink A. L., Wilson M. A., Structural impact of three Parkinsonism-associated missense mutations on human DJ-1. Biochemistry 2008 47 5 1381 1392 2-s2.0-38849197935 10.1021/bi701189c
69. Irrcher I., Aleyasin H., Seifert E. L., Hewitt S. J., Chhabra S., Phillips M., Lutz A. K., Rousseaux M. W. C., Bevilacqua L., Jahani-Asl A., Callaghan S., MacLaurin J. G., Winklhofer K. F., Rizzu P., Rippstein P., Kim R. H., Chen C. X., Fon E. A., Slack R. S., Harper M. E., McBride H. M., Mak T. W., Park D. S., Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Human Molecular Genetics 2010 19 19 3734 3746 2-s2.0-77956522541 10.1093/hmg/ddq288 ddq288
70. Larsen N. J., Ambrosi G., Mullett S. J., Berman S. B., Hinkle D. A., DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience 2011 196 251 264 2-s2.0-80054051722 10.1016/j.neuroscience.2011.08.016
71. Kim S. J., Park Y. J., Hwang I. Y., Youdim M. B., Park K. S., Oh Y. J., Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death. Free Radical Biology and Medicine 2012 53 4 936 950
72. Junn E., Jang W. H., Zhao X., Jeong B. S., Mouradian M. M., Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. Journal of Neuroscience Research 2009 87 1 123 129 2-s2.0-63049138430 10.1002/jnr.21831
73. Gu L., Cui T., Fan C., Zhao H., Zhao C., Lu L., Yang H., Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress. Biochemical and Biophysical Research Communications 2009 383 4 469 474 2-s2.0-67349264491 10.1016/j.bbrc.2009.04.037
74. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T. M., Thomas B., Han S. K., Sasaki M., Ischiropoulos H., Przedborski S., Dawson T. M., Dawson V. L., DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proceedings of the National Academy of Sciences of the United States of America 2007 104 37 14807 14812 2-s2.0-35548972027 10.1073/pnas.0703219104
75. Canet-Avilés R. M., Wilson M. A., Miller D. W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M. J., Ringe D., Petsko G. A., Cookson M. R., The Parkinson's disease DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proceedings of the National Academy of Sciences of the United States of America 2004 101 24 9103 9108 2-s2.0-2942684871 10.1073/pnas.0402959101
76. Waak J., Weber S. S., Görner K., Schall C., Ichijo H., Stehle T., Kahle P. J., Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. Journal of Biological Chemistry 2009 284 21 14245 14257 2-s2.0-67649771389 10.1074/jbc.M806902200
77. Wilson M. A., The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxidants and Redox Signaling 2011 15 1 111 122 2-s2.0-79958199102 10.1089/ars.2010.3481
78. Zhong N., Xu J., Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1 α;: regulation by SUMOylation and oxidation. Human Molecular Genetics 2008 17 21 3357 3367 2-s2.0-54449096831 10.1093/hmg/ddn230
79. Im J. Y., Lee K. W., Woo J. M., Junn E., Mouradian M. M., DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Human Molecular Genetics 2012 21 13 3013 3024
80. Ren H., Fu K., Wang D., Mu C., Wang G., Oxidized DJ-1 interacts with the mitochondrial protein BCL-XL. Journal of Biological Chemistry 2011 286 40 35308 35317 2-s2.0-80053399227 10.1074/jbc.M110.207134
81. Zhou W., Zhu M., Wilson M. A., Petsko G. A., Fink A. L., The oxidation state of DJ-1 regulates its chaperone activity toward α; -synuclein. Journal of Molecular Biology 2006 356 4 1036 1048 2-s2.0-31344464179 10.1016/j.jmb.2005.12.030
82. McCoy M. K., Cookson M. R., DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy 2011 7 5 531 532 2-s2.0-79955701611 10.4161/auto.7.5.14684
83. McCord J. M., Fridovich I., Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry 1969 244 22 6049 6055 2-s2.0-0014691242
84. Lindenau J., Noack H., Possel H., Asayama K., Wolf G., Cellular distribution of superoxide dismutases in the rat CNS. Glia 2000 29 1 25 34
85. Kurobe N., Suzuki F., Okajima K., Kato K., Sensitive enzyme immunoassay for human Cu/Zn superoxide dismutase. Clinica Chimica Acta 1990 187 1 11 20 2-s2.0-0025095410 10.1016/0009-8981(90)90257-S
86. Pesaresi M. G., Amori I., Giorgi C., Ferri A., Fiorenzo P., Gabanella F., Salvatore A. M., Giorgio M., Pelicci P. G., Pinton P., Carrì M. T., Cozzolino M., Mitochondrial redox signalling by p66Shc mediates ALS-like disease through Rac1 inactivation. Human Molecular Genetics 2011 20 21 4196 4208 2-s2.0-80053959138 10.1093/hmg/ddr347 ddr347
87. Etienne-Manneville S., Hall A., Rho GTPases in cell biology. Nature 2002 420 6916 629 635 2-s2.0-0037069690 10.1038/nature01148
88. Harraz M. M., Marden J. J., Zhou W., Zhang Y., Williams A., Sharov V. S., Nelson K., Luo M., Paulson H., Schöneich C., Engelhardt J. F., SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. Journal of Clinical Investigation 2008 118 2 659 670 2-s2.0-38849182472 10.1172/JCI34060
89. Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.-F., Crow J. P., Cashman N. R., Kondejewski L. H., Chakrabartty A., Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. Journal of Biological Chemistry 2002 277 49 47551 47556 2-s2.0-0347155578 10.1074/jbc.M207356200
90. Lev N., Ickowicz D., Barhum Y., Melamed E., Offen D., DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. Journal of Molecular Neuroscience 2009 38 2 94 102 2-s2.0-69249214308 10.1007/s12031-008- 9138-7
91. Yamashita S., Mori A., Kimura E., Mita S., Maeda Y., Hirano T., Uchino M., DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity. Journal of Neurochemistry 2010 113 4 860 870 2-s2.0-77950956658 10.1111/j.1471-4159. 2010.06658.x
92. Jung K.-A., Kwak M.-K., The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 2010 15 10 7266 7291 2-s2.0-78149434112 10.3390/molecules15107266
93. Kobayashi M., Yamamoto M., Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidants and Redox Signaling 2005 7 3-4 385 394 2-s2.0-14044254798 10.1089/ars.2005.7.385
94. Villeneuve N. F., Lau A., Zhang D. D., Regulation of the Nrf2-keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxidants and Redox Signaling 2010 13 11 1699 1712 2-s2.0-77958115724 10.1089/ars.2010.3211
95. Milani P., Gagliardi S., Cova E., Cereda C., SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS. Neurology Research International 2011 2011 9 458427 10.1155/2011/458427
96. Yenki P., Khodagholi F., Shaerzadeh F., Inhibition of phosphorylation of JNK suppresses Abeta-induced ER stress and upregulates prosurvival mitochondrial proteins in rat hippocampus. Journal of Molecular Neuroscience 2013 49 2 262 269
97. Clements C. M., McNally R. S., Conti B. J., Mak T. W., Ting J. P.-Y., DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proceedings of the National Academy of Sciences of the United States of America 2006 103 41 15091 15096 2-s2.0-33750052885 10.1073/pnas.0607260103
98. Gan L., Johnson D. A., Johnson J. A., Keap1-Nrf2 activation in the presence and absence of DJ-1. European Journal of Neuroscience 2010 31 6 967 977 2-s2.0-77949550917 10.1111/j.1460-9568.2010.07138.x
99. Hwang O., Role of oxidative stress in Parkinson's disease. Experimental Neurobiology 2013 22 11 17
100. Pehar M., Vargas M. R., Robinson K. M., Cassina P., Díaz-Amarilla P. J., Hagen T. M., Radi R., Barbeito L., Beckman J. S., Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis. Journal of Neuroscience 2007 27 29 7777 7785 2-s2.0-34447633192 10.1523/JNEUROSCI.0823-07. 2007
101. Kraft A. D., Resch J. M., Johnson D. A., Johnson J. A., Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Experimental Neurology 2007 207 1 107 117 2-s2.0-34548287969 10.1016/j.expneurol.2007.05.026
102. Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11908 11913 2-s2.0-0037015035 10.1073/pnas.172398899
103. Hong F., Freeman M. L., Liebler D. C., Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chemical Research in Toxicology 2005 18 12 1917 1926 2-s2.0-29644443964 10.1021/tx0502138
104. Jiang H., Tian X., Guo Y., Duan W., Bu H., Li C., Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity. Biological and Pharmaceutical Bulletin 2011 34 8 1194 1197 2-s2.0-80051500260 10.1248/bpb.34.1194
105. Wu J., Li Q., Wang X., Yu S., Li L., Wu X., Chen Y., Zhao J., Zhao Y., Neuroprotection by curcumin in ischemic brain injury involves the akt/nrf2 pathway. PLoS One 2013 8 e59843
106. Son T. G., Kawamoto E. M., Yu Q. S., Greig N. H., Mattson M. P., Camandola S., Naphthazarin protects against glutamate-induced neuronal death via activation of the Nrf2/ARE pathway. Biochemical and Biophysical Research Communications 2013 433 4 602 606
107. Wang R., Tu J., Zhang Q., Zhang X., Zhu Y., Ma W., Cheng C., Brann D. W., Yang F., Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO-1 signaling. Hippocampus 2013 23 7 634 647 10.1002/hipo.22126
108. Satoh T., Kosaka K., Itoh K., Kobayashi A., Yamamoto M., Shimojo Y., Kitajima C., Cui J., Kamins J., Okamoto S.-I., Izumi M., Shirasawa T., Lipton S. A., Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. Journal of Neurochemistry 2008 104 4 1116 1131 2-s2.0-38449111059 10.1111/j.1471-4159.2007.05039.x
109. Chen J. H., Ou H. P., Lin C. Y., Lin F. J., Wu C. R., Chang S. W., Tsai C. W., Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chemical Research in Toxicology 2012 25 9 1893 1901
110. Koh S.-H., Kwon H., Kim K. S., Kim J., Kim M.-H., Yu H.-J., Kim M., Lee K.-W., Do B. R., Jung H. K., Yang K.-W., Appel S. H., Kim S. H., Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals. Toxicology 2004 202 3 213 225 2-s2.0-4444356826 10.1016/j.tox.2004.05.008
111. Hou R.-R., Chen J.-Z., Chen H., Kang X.-G., Li M.-G., Wang B.-R., Neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells. Cell Biology International 2008 32 1 22 30 2-s2.0-39049122007 10.1016/j.cellbi.2007.08.007
112. Koh S.-H., Lee S. M., Kim H. Y., Lee K.-Y., Lee Y. J., Kim H.-T., Kim J., Kim M.-H., Hwang M. S., Song C., Yang K.-W., Lee K. W., Kim S. H., Kim O.-H., The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neuroscience Letters 2006 395 2 103 107 2-s2.0-31944446417 10.1016/j.neulet.2005.10.056
113. Xu Z., Chen S., Li X., Luo G., Li L., Le W., Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochemical Research 2006 31 10 1263 1269 2-s2.0-33750718502 10.1007/s11064-006-9166-z
114. Romeo L., Intrieri M., D'Agata V., Mangano N. G., Oriani G., Ontario M. L., Scapagnini G., The major green tea polyphenol, (-)-epigallocatechin-3- gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. Journal of the American College of Nutrition 2009 28 supplement 492S 499S 2-s2.0-77951546947
115. Kesherwani V., Atif F., Yousuf S., Agrawal S. K., Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2. Neuroscience 2013 241 80 88
116. Vincent A. M., Kato K., McLean L. L., Soules M. E., Feldman E. L., Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxidants and Redox Signaling 2009 11 3 425 438 2-s2.0-58849107536 10.1089/ars.2008.2235
117. Kaidery N. A., Banerjee R., Yang L., Smirnova N. A., Hushpulian D. M., Liby K. T., Williams C. R., Yamamoto M., Kensler T. W., Ratan R. R., Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease. Antioxidants & Redox Signaling 2013 18 2 139 157
118. Neymotin A., Calingasan N. Y., Wille E., Naseri N., Petri S., Damiano M., Liby K. T., Risingsong R., Sporn M., Beal M. F., Kiaei M., Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology and Medicine 2011 51 1 88 96 2-s2.0-79957959973 10.1016/j.freeradbiomed.2011.03.027
119. Kanno T., Tanaka K., Yanagisawa Y., Yasutake K., Hadano S., Yoshii F., Hirayama N., Ikeda J. E., A novel small molecule, N-(4-(2-pyridyl)(1, 3-thiazol-2-yl))-2-(2, 4, 6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS. Free Radical Biology and Medicine 2012 53 11 2028 2042
120. Lim J. H., Kim K.-M., Kim S. W., Hwang O., Choi H. J., Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Pharmacological Research 2008 57 5 325 331 2-s2.0-44549085003 10.1016/j.phrs.2008.03.004
121. Kalra S., Zhang Y., Knatko E. V., Finlayson S., Yamamoto M., Dinkova-Kostova A. T., Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway. Cancer Prevention Research 2011 4 10 1665 1674 2-s2.0-80053909017 10.1158/1940-6207.CAPR-11-0137
122. Vargas M. R., Johnson D. A., Sirkis D. W., Messing A., Johnson J. A., Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. Journal of Neuroscience 2008 28 50 13574 13581 2-s2.0-58149379610 10.1523/JNEUROSCI.4099-08.2008
123. Vargas M. R., Burton N. C., Kutzke J., Gan L., Johnson D. A., Schafer M., Werner S., Johnson J. A., Absence of Nrf2 or its selective overexpression in neurons and muscle does not affect survival in ALS-linked mutant hSOD1 mouse models. PLoS One 2013 8 article e56625
124. Guo Y., Zhang Y., Wen D., Duan W., An T., Shi P., Wang J., Li Z., Chen X., Li C., The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model. Laboratory Investigation 2013 93 7 825 833
125. Na H.-K., Surh Y.-J., Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food and Chemical Toxicology 2008 46 4 1271 1278 2-s2.0-39249085843 10.1016/j.fct.2007.10.006
126. Kelsey N. A., Wilkins H. M., Linseman D. A., Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010 15 11 7792 7814 2-s2.0-78649467294 10.3390/molecules15117792
127. Ma W., Yuan L., Yu H., Ding B., Xi Y., Feng J., Xiao R., Genistein as a
128. Xi Y.-D., Yu H.-L., Ding J., Ma W.-W., Yuan L.-H., Feng J.-F., Xiao Y.-X., Xiao R., Flavonoids protect cerebrovascular endothelial cells through Nrf2 and PI3K from β -amyloid peptide-induced oxidative damage. Current Neurovascular Research 2012 9 1 32 41 2-s2.0-84858260704 10.2174/ 156720212799297092